Work

POSTER: ABCL-736: Outpatient Treatment With Glofitamab Plus Gemcitabine and Oxaliplatin in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Preliminary Safety Results From a Phase 2 Study

Year: 2026

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)01116-x

Authors: Dok Hyun Yoon, David Berz, Carmelo Carlo-Stella, Rami Kotb, Jeong-Ok Lee, Charles Herbaux, Robert Puckrin, Vanja Zeremski, Lucile Bussot, Gerardo Musuraca, Ritika Jagtiani, Juana Hernandez, Grace Smithen, Isabel Prieto Gonzalez-Albo, Linda Lundberg, James Relf, John M Burke

Institutions: Asan Medical Center, University of Ulsan, Humanitas University, IRCCS Humanitas Research Hospital, CancerCare Manitoba, University of Manitoba, Seoul National University, Seoul National University Bundang Hospital, Centre Hospitalier Universitaire de Montpellier, University of Calgary, Arthur J.E. Child Comprehensive Cancer Centre, Otto-von-Guericke-Universität Magdeburg, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Genentech, F. Hoffmann-La Roche AG, Roche (United Kingdom), Sarah Cannon, Rocky Mountain Cancer Centers

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204701788

FWCI:

Cites:

Cited by:

Related to: 10